Amplitude Therapeutics, Inc.

UEI
LKKRWNJ3WQN7
CAGE
9VMN7
Primary NAICS
541714 Research and Development in Biotechnology (except Nanobiotechnology)
SAM.gov registration
Expired

Company facts

Self-certified in SAM.gov
  • For Profit Organization
Entity structure
Corporate Entity (Not Tax Exempt)
NAICS codes registered in SAM.gov
SAM.gov registration date

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Recent federal awards

Amplitude Therapeutics, Inc.'s latest federal award, newest first. Amounts are dollars obligated.
Award Agency Obligated Awarded
Amplitude therapeutics-a split-formulated trans-amplifying RNA encoded anti-neuraminidase monoclonal antibody Contract · 75A50124C00036 Office of the Assistant Secretary for Preparedness and Response $732,813

Quick answers

What is Amplitude Therapeutics, Inc.'s UEI?

Amplitude Therapeutics, Inc.'s Unique Entity ID (UEI) in SAM.gov is LKKRWNJ3WQN7.

What is Amplitude Therapeutics, Inc.'s CAGE code?

Amplitude Therapeutics, Inc.'s CAGE code is 9VMN7.

What is Amplitude Therapeutics, Inc.'s primary NAICS code?

Amplitude Therapeutics, Inc.'s primary NAICS code is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)).

Is Amplitude Therapeutics, Inc. registered in SAM.gov?

Amplitude Therapeutics, Inc.'s SAM.gov registration expired on March 17, 2026.

What is Amplitude Therapeutics, Inc.'s most recent federal award?

Amplitude Therapeutics, Inc.'s most recent federal contract award is Amplitude therapeutics-a split-formulated trans-amplifying RNA encoded anti-neuraminidase monoclonal antibody (75A50124C00036), from Office of the Assistant Secretary for Preparedness and Response, on August 20, 2024.

On GovTribe

See Amplitude Therapeutics, Inc.'s full federal record

  • Federal contract awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors